Trials / Completed
CompletedNCT05645393
Effect of Estradiol Topical Products
Confirming Quality Performance of Extemporaneously Compounded Estrogen Hormone Products
- Status
- Completed
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 4 (actual)
- Sponsor
- University of Maryland, Baltimore · Academic / Other
- Sex
- Female
- Age
- 45 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The aim of the present study is to determine if two products can deliver bioequivalent amounts of estrogen (estradiol, estriol, and estrone).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | topical estrogen product | estrogen topical gel or cream |
Timeline
- Start date
- 2024-06-05
- Primary completion
- 2025-03-30
- Completion
- 2025-03-30
- First posted
- 2022-12-09
- Last updated
- 2025-05-20
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05645393. Inclusion in this directory is not an endorsement.